Lift Global Ventures PLC Investee Company Update
2023年9月20日 - 3:00PM
RNSニュース (英語)
TIDMLFT
Lift Global Ventures PLC
20 September 2023
20 September 2023
Lift Global Ventures Plc
("Lift" or the "Company")
Investee Company Update
Lift Global Ventures Plc (AQSE:LFT) , an investment company
focused on financial media, technology and the energy sector, is
pleased to announce that its investee company, Public Relations and
Investor Relations company, Miriad Limited, has been appointed by
Imperial Diagnostix Laboratories Limited as its Corporate
Communications Agency. IDL is in the run up to a planned IPO in
2024, for which Miriad will be responsible for the distribution of
all necessary documentation for potential investors to make an
informed decision about the future of Imperial Diagnostix
Laboratories Ltd and their possible and subsequent financial
involvement.
Zak Mir, CEO Lift Global Ventures said , "We are delighted to
welcome Imperial Diagnostix at such a key point in their journey
towards IPO. IDL appreciate that in challenging markets, it is
during the time of the fund raise when corporate communications and
strategy are most important. Miriad looks forward to welcoming many
other companies at similar stages in their development.
About Imperial Diagnostix Ltd:
Imperial Diagnostix Laboratories Ltd., a leading provider of
diagnostic products and services, is pleased to share its recent
accomplishments in August 2023. Firstly, they are pleased to
announce that they have been granted access to the NHS supply chain
in the UK, allowing them to extend their services and products to
healthcare professionals across the nation.
Additionally, IDL has received certifications from the Ministry
of Health (MHRA) in UK, CE certification in Europe and
certification in Ghana, Nigeria and the UAE. In addition, they have
successfully completed trials with partners in Mauritius, who will
also represent The Seychelles, and Madagascar. These achievements
mark a significant expansion of Imperial Diagnostix's global
presence and further solidify their position in the Point of Care
industry.
In summary, IDL stands as the UK's foremost provider of
high-quality diagnostic solutions, delivering advanced Point of
Care Testing (POCT) technologies to healthcare professionals. With
a solid commitment to innovation and excellence, IDL intends to
enhance patient outcome and support healthcare providers in
expanding the parameters of In Vitro Fluorescence diagnostics
globally.
IDL is already spearheading an initiative to support a
government mandate to increase the number of diagnostic screening
centres in the UK and by cultivating partnerships within practices
and surgeries in both private and public healthcare sectors, they
intend to support this initiative with their catalogue of
cutting-edge diagnostic testing products.
Richard Paine Smith, CEO Imperial Diagnostix said , "As IDL have
recently become aligned with the NHS Supply Chain, we will be
targeting all of the National Health hospitals, clinics, surgeries
and GPs to bring diagnostics and point of care to the source. In
line with a government initiative, to reduce waiting times and
expediting the availability to screen potentially life-threatening
illnesses, IDL have the resources to fill the void for which the
government have apparently allocated a budget of GBP1.6 Billion to,
give the public control of their own health. In addition, IDL can
identify how we can save the NHS considerable funds, increasing
efficiency and potentially saving many lives.
About Miriad Ltd:
Miriad Limited, a financial PR and IR consulting company run by
well-known stock market commentator and current Director, Zak Mir.
Miriad provides a bespoke, personalised service to small/mid-cap
entities in the UK and access to Zak's deep market insights, vast
industry connections and significant social media including 24,000
on X (formerly Twitter).
Enquiries:
Lift Global Ventures Plc
Zak Mir, CEO
Sandy Barblett, Non-Executive Director +44 (0)203 745 1865
--------------------
Optiva Securities (AQSE Corporate
Adviser and Broker)
--------------------
Christian Dennis
Daniel Ingram +44 (0)203 411 1881
--------------------
For more information please visit: www.liftgv.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRASFFFWUEDSELU
(END) Dow Jones Newswires
September 20, 2023 02:00 ET (06:00 GMT)
Lift Global Ventures (AQSE:LFT)
過去 株価チャート
から 4 2024 まで 5 2024
Lift Global Ventures (AQSE:LFT)
過去 株価チャート
から 5 2023 まで 5 2024